Clinical studies in humans have not been published so far ( Development, preclinical, and early clinical data on the GIP/GLP-1 receptor agonist tirzepatide Among the GIP/GLP-1 receptor agonists, tirzepatide (LY3298176) is the compound that is the most advanced in development and the first substance in this class that has received approval for the therapy of T2D by the FDA in May 2022 (manufacturer Eli Lilly Comp., trade name Mounjaro ) ( Pharmacodynamics Tirzepatide is a GIP/GLP-1 chimeric peptide with a peptide chain length of 39 amino acids
Saxenda (liraglutide) Its an older daily injectable GLP-1 approved for weight management
Any form of significant weight loss, including calorie restriction or bariatric surgery, typically results in some degree of lean mass loss
L-Carnitine 500 , from Vitobest , is a supplement based on L-Carnitine tartrate from Carnipure , the highest quality carnitine on the market
Theyve even earned FDA approval for obesity treatment and are increasingly being prescribed for conditions like metabolic syndrome, prediabetes, and weight management